Provided by Tiger Fintech (Singapore) Pte. Ltd.

Monte Rosa Therapeutics

4.22
+0.37009.61%
Volume:671.53K
Turnover:2.73M
Market Cap:259.57M
PE:-4.29
High:4.62
Open:4.57
Low:3.76
Close:3.85
Loading ...

Monte Rosa Therapeutics: Promising Developments and Financial Stability Support Buy Rating

TIPRANKS
·
17 hours ago

Monte Rosa Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
Yesterday

Monte Rosa Therapeutics Q1 EPS $0.57 Beats $(0.30) Estimate, Sales $84.93M Beat $14.25M Estimate

Benzinga
·
Yesterday

BRIEF-Monte Rosa Therapeutics Q1 Net Income USD 47.707 Million

Reuters
·
Yesterday

Monte Rosa Therapeutics Inc: Cash Position Expected to Fund Operations Into 2028

THOMSON REUTERS
·
Yesterday

Press Release: Monte Rosa Therapeutics Announces First Quarter 2025 Financial Results and Business Updates

Dow Jones
·
Yesterday

Monte Rosa Therapeutics Inc expected to post a loss of 34 cents a share - Earnings Preview

Reuters
·
05 May

Promising Developments in Cancer Treatment: Monte Rosa Therapeutics’ MRT-51443 Gains Buy Rating

TIPRANKS
·
29 Apr

Monte Rosa Therapeutics Presents Preclinical Data at American Association for Cancer Research (AACR) Annual Meeting 2025 on the Potential of its CDK2-directed Molecular Glue Degrader to Treat HR-positive/HER2-negative Breast Cancer

GlobeNewswire
·
28 Apr

Monte Rosa Therapeutics Insider Ups Holding During Year

Simply Wall St.
·
23 Apr

Monte Rosa Therapeutics Is Maintained at Outperform by Wedbush

Dow Jones
·
21 Mar

Wedbush Adjusts Price Target on Monte Rosa Therapeutics to $17 From $15, Maintains Outperform Rating

MT Newswires Live
·
21 Mar

Promising Clinical Developments and Strategic Partnerships Drive Buy Rating for Monte Rosa Therapeutics

TIPRANKS
·
21 Mar

Monte Rosa Therapeutics Inc : Wells Fargo Cuts Target Price to $10 From $11

THOMSON REUTERS
·
21 Mar

Wells Fargo Reaffirms Their Hold Rating on Monte Rosa Therapeutics (GLUE)

TIPRANKS
·
21 Mar

U.S. RESEARCH ROUNDUP-Darden Restaurants, Nike, Optinose

Reuters
·
21 Mar

Monte Rosa Therapeutics Inc : JP Morgan Cuts Target Price to $12 From $15

THOMSON REUTERS
·
21 Mar

Monte Rosa Therapeutics Inc : Wedbush Raises Target Price to $17 From $15

THOMSON REUTERS
·
21 Mar

Monte Rosa Therapeutics Files $400 Million Mixed Shelf

MT Newswires Live
·
20 Mar

Monte Rosa Therapeutics Inc - Files for Mixed Shelf Offering of $400 Mln

THOMSON REUTERS
·
20 Mar